Journal of Antimicrobial Chemotherapy, Vol 39, 163-167, Copyright © 1997 by The British Society for Antimicrobial Chemotherapy
I Pujol, J Guarro, J Gene and J Sala
The MICs of amphotericin B, miconazole, ketoconazole, flucytosine,
itraconazole and fluconazole for 19 isolates of Fusarium oxysporum, 16
Fusarium solani, seven Fusarium verticilliodes, four Fusarium proliferatum,
four Fusarium dimerum, three Fusarium equiseti, and one each of the
following species: Fusarium graminearum, Fusarium chlamydosporum, Fusarium
semitectum, Fusarium avenaceum and Fusarium subglutinans were determined by
a broth microdilution method. Thirty- eight of these isolates were of
clinical origin and 20 from environmental sources. In general, Fusarium
spp. strains showed resistance to all the antifungals tested. However, the
most active agent was amphotericin B. Fluconazole and flucytosine were not
active against any of the isolates tested. A correlation study of in-vitro
testing with in-vivo outcome of amphotericin B of the cases of disseminated
fusarium infections published is reported.
JOURNAL ARTICLE
In-vitro antifungal susceptibility of clinical and environmental Fusarium spp. strains
Laboratori de Microbiologia, Hospital Universitari Sant Joan de Reus, Spain.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M. Azor, J. Gene, J. Cano, P. Manikandan, N. Venkatapathy, and J. Guarro Less-Frequent Fusarium Species of Clinical Interest: Correlation between Morphological and Molecular Identification and Antifungal Susceptibility J. Clin. Microbiol., May 1, 2009; 47(5): 1463 - 1468. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Oechsler, M. R. Feilmeier, D. R. Ledee, D. Miller, M. R. Diaz, M. E. Fini, J. W. Fell, and E. C. Alfonso Utility of Molecular Sequence Analysis of the ITS rRNA Region for Identification of Fusarium spp. from Ocular Sources Invest. Ophthalmol. Vis. Sci., May 1, 2009; 50(5): 2230 - 2236. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. O'Donnell, D. A. Sutton, A. Fothergill, D. McCarthy, M. G. Rinaldi, M. E. Brandt, N. Zhang, and D. M. Geiser Molecular Phylogenetic Diversity, Multilocus Haplotype Nomenclature, and In Vitro Antifungal Resistance within the Fusarium solani Species Complex J. Clin. Microbiol., August 1, 2008; 46(8): 2477 - 2490. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Azor, J. Gene, J. Cano, D. A. Sutton, A. W. Fothergill, M. G. Rinaldi, and J. Guarro In Vitro Antifungal Susceptibility and Molecular Characterization of Clinical Isolates of Fusarium verticillioides (F. moniliforme) and Fusarium thapsinum Antimicrob. Agents Chemother., June 1, 2008; 52(6): 2228 - 2231. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Azor, J. Gene, J. Cano, and J. Guarro Universal In Vitro Antifungal Resistance of Genetic Clades of the Fusarium solani Species Complex Antimicrob. Agents Chemother., April 1, 2007; 51(4): 1500 - 1503. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Ferrer, J. Alio, A. Rodriguez, M. Andreu, and F. Colom Endophthalmitis Caused by Fusarium proliferatum J. Clin. Microbiol., October 1, 2005; 43(10): 5372 - 5375. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J. Dornbusch, W. Buzina, R. C. Summerbell, C. Lass-Florl, H. Lackner, W. Schwinger, P. Sovinz, and C. Urban Fusarium verticillioides Abscess of the Nasal Septum in an Immunosuppressed Child: Case Report and Identification of the Morphologically Atypical Fungal Strain J. Clin. Microbiol., April 1, 2005; 43(4): 1998 - 2001. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Guarro, C. Rubio, J. Gene, J. Cano, J. Gil, R. Benito, M. J. Moranderia, and E. Miguez Case of Keratitis Caused by an Uncommon Fusarium Species J. Clin. Microbiol., December 1, 2003; 41(12): 5823 - 5826. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Lionakis, R. E. Lewis, G. Samonis, and D. P. Kontoyiannis Pentamidine Is Active In Vitro against Fusarium Species Antimicrob. Agents Chemother., October 1, 2003; 47(10): 3252 - 3259. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. I. Paphitou, L. Ostrosky-Zeichner, V. L. Paetznick, J. R. Rodriguez, E. Chen, and J. H. Rex In Vitro Activities of Investigational Triazoles against Fusarium Species: Effects of Inoculum Size and Incubation Time on Broth Microdilution Susceptibility Test Results Antimicrob. Agents Chemother., October 1, 2002; 46(10): 3298 - 3300. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ortoneda, J. Capilla, F. J. Pastor, I. Pujol, and J. Guarro Efficacy of Liposomal Amphotericin B in Treatment of Systemic Murine Fusariosis Antimicrob. Agents Chemother., July 1, 2002; 46(7): 2273 - 2275. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Letscher-Bru, F. Campos, J. Waller, R. Randriamahazaka, E. Candolfi, and R. Herbrecht Successful Outcome of Treatment of a Disseminated Infection Due to Fusarium dimerum in a Leukemia Patient J. Clin. Microbiol., March 1, 2002; 40(3): 1100 - 1102. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Capilla, M. Ortoneda, F. J. Pastor, and J. Guarro In Vitro Antifungal Activities of the New Triazole UR-9825 against Clinically Important Filamentous Fungi Antimicrob. Agents Chemother., September 1, 2001; 45(9): 2635 - 2637. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Guarro, M. Nucci, T. Akiti, and J. Gené Mixed Infection Caused by Two Species of Fusarium in a Human Immunodeficiency Virus-Positive Patient J. Clin. Microbiol., September 1, 2000; 38(9): 3460 - 3462. [Abstract] [Full Text] |
||||
![]() |
J. Guarro, M. Nucci, T. Akiti, J. Gené, M. D. G. C. Barreiro, and R. T. Gonçalves Fungemia Due to Fusarium sacchari in an Immunosuppressed Patient J. Clin. Microbiol., January 1, 2000; 38(1): 419 - 421. [Abstract] [Full Text] |
||||
![]() |
J. Guarro, M. Nucci, T. Akiti, J. Gené, J. Cano, M. D. G. C. Barreiro, and C. Aguilar Phialemonium Fungemia: Two Documented Nosocomial Cases J. Clin. Microbiol., August 1, 1999; 37(8): 2493 - 2497. [Abstract] [Full Text] |
||||
![]() |
C. Aguilar, I. Pujol, and J. Guarro In Vitro Antifungal Susceptibilities of Scopulariopsis Isolates Antimicrob. Agents Chemother., June 1, 1999; 43(6): 1520 - 1522. [Abstract] [Full Text] |
||||
![]() |
J. Guarro, I. Pujol, and E. Mayayo In Vitro and In Vivo Experimental Activities of Antifungal Agents against Fusarium solani Antimicrob. Agents Chemother., May 1, 1999; 43(5): 1256 - 1257. [Abstract] [Full Text] |
||||
![]() |
E. M. Johnson, A. Szekely, and D. W. Warnock In Vitro Activity of Syn-2869, a Novel Triazole Agent, against Emerging and Less Common Mold Pathogens Antimicrob. Agents Chemother., May 1, 1999; 43(5): 1260 - 1263. [Abstract] [Full Text] |
||||
![]() |
A. Szekely, E. M. Johnson, and D. W. Warnock Comparison of E-Test and Broth Microdilution Methods for Antifungal Drug Susceptibility Testing of Molds J. Clin. Microbiol., May 1, 1999; 37(5): 1480 - 1483. [Abstract] [Full Text] |
||||
![]() |
M. Lozano-Chiu, S. Arikan, V. L. Paetznick, E. J. Anaissie, D. Loebenberg, and J. H. Rex Treatment of Murine Fusariosis with SCH 56592 Antimicrob. Agents Chemother., March 1, 1999; 43(3): 589 - 591. [Abstract] [Full Text] |
||||
![]() |
C. Aguilar, I. Pujol, J. Sala, and J. Guarro Antifungal Susceptibilities of Paecilomyces Species Antimicrob. Agents Chemother., July 1, 1998; 42(7): 1601 - 1604. [Abstract] [Full Text] |
||||


